These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33455096)

  • 1. CXCL13/CXCR5 are potential biomarkers for diagnosis and prognosis for breast cancer.
    Jiang L; Wang D; Sheng M; Tong D; Liu H; Dong L; Ma J
    J BUON; 2020; 25(6):2552-2561. PubMed ID: 33455096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
    Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
    Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.
    Qi XW; Xia SH; Yin Y; Jin LF; Pu Y; Hua D; Wu HR
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1916-24. PubMed ID: 25010623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
    Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
    Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
    Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
    Panse J; Friedrichs K; Marx A; Hildebrandt Y; Luetkens T; Barrels K; Horn C; Stahl T; Cao Y; Milde-Langosch K; Niendorf A; Kröger N; Wenzel S; Leuwer R; Bokemeyer C; Hegewisch-Becker S; Atanackovic D
    Br J Cancer; 2008 Sep; 99(6):930-8. PubMed ID: 18781150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of CXCL13 and CXCL9 in Early Breast Cancer.
    Razis E; Kalogeras KT; Kotsantis I; Koliou GA; Manousou K; Wirtz R; Veltrup E; Patsea H; Poulakaki N; Dionysopoulos D; Pervana S; Gogas H; Koutras A; Pentheroudakis G; Christodoulou C; Linardou H; Pavlakis K; Koletsa T; Pectasides D; Zagouri F; Fountzilas G
    Clin Breast Cancer; 2020 Feb; 20(1):e36-e53. PubMed ID: 31699671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL13/CXCR5 signaling axis in cancer.
    Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
    Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.
    Chen L; Huang Z; Yao G; Lyu X; Li J; Hu X; Cai Y; Li W; Li X; Ye C
    J Transl Med; 2015 May; 13():168. PubMed ID: 25990390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL13 inhibition induce the apoptosis of MDA-MB-231 breast cancer cells through blocking CXCR5/ERK signaling pathway.
    Ma JJ; Jiang L; Tong DY; Ren YN; Sheng MF; Liu HC
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8755-8762. PubMed ID: 30575916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling via the CXCR5/ERK pathway is mediated by CXCL13 in mice with breast cancer.
    Xu L; Liang Z; Li S; Ma J
    Oncol Lett; 2018 Jun; 15(6):9293-9298. PubMed ID: 29844827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
    Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
    Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats.
    Li R; Ma L; Huang H; Ou S; Yuan J; Xu T; Yu X; Liu X; Yang J; Chen Y; Peng X
    Neurochem Res; 2017 Feb; 42(2):526-540. PubMed ID: 27873133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
    Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
    J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection.
    Steinmetz OM; Panzer U; Kneissler U; Harendza S; Lipp M; Helmchen U; Stahl RA
    Kidney Int; 2005 Apr; 67(4):1616-21. PubMed ID: 15780119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and application of chemokine CXCL13 in central nervous system lymphoma.
    Li C; Zhang L; Jin Q; Jiang H; Wu C
    Ann Hematol; 2024 Aug; 103(8):2671-2680. PubMed ID: 38010409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
    Pimenta EM; De S; Weiss R; Feng D; Hall K; Kilic S; Bhanot G; Ganesan S; Ran S; Barnes BJ
    Immunol Cell Biol; 2015; 93(5):486-99. PubMed ID: 25533286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
    Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
    Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.